Back
Grand Canyon Education Vs. Tandem Diabetes Care Industry Stock Comparison
Sell
43
LOPE
Grand Canyon Education
Last Price:
137.70
Seasonality Move:
-1.21%
Sell
46
TNDM
Tandem Diabetes Care
Last Price:
45.38
Seasonality Move:
20.45%
Sell
43
Grand Canyon Education (LOPE)
is a Sell
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $137.58. The Score for LOPE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- LOPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Tandem Diabetes Care (TNDM)
is a Sell
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $45.33. The Score for TNDM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- TNDM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $137.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LOPE is experiencing slight buying pressure.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $45.33
The current trend is moderately bearish and TNDM is experiencing buying pressure, which is a positive indicator for future bullish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 39.33 | Sell |
| Chaikin Money Flow: | 48897 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.75 - 146.41) | Sell |
| Bollinger Bands (100): | (129.56 - 141.22) | Buy |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 44.36 | Sell |
| Chaikin Money Flow: | 864407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.03 - 51.67) | Sell |
| Bollinger Bands (100): | (25.46 - 44.48) | Buy |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 140.84 | Sell |
| 20-day SMA: | 142.98 | Sell |
| 50-day SMA: | 138.34 | Sell |
| 200-day SMA: | 130.68 | Buy |
| 8-day EMA: | 140.14 | Sell |
| 20-day EMA: | 141.39 | Sell |
| 50-day EMA: | 139.48 | Sell |
| 200-day EMA: | 130.54 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.18 | Sell |
| 20-day SMA: | 49.73 | Sell |
| 50-day SMA: | 42.42 | Buy |
| 200-day SMA: | 28.56 | Buy |
| 8-day EMA: | 47.67 | Sell |
| 20-day EMA: | 47.9 | Sell |
| 50-day EMA: | 43.47 | Buy |
| 200-day EMA: | 34.22 | Buy |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.86 per share, and an increase next year of $0.85 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
Grand Canyon Education Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||